- Noteworthy events for the week of Feb. 18 - 24 for healthcare investors:
-
Monday (2/19): CAGNY Conference, Boca Raton, FL (five days). Johnson & Johnson (NYSE:JNJ).
-
Tuesday (2/20): Conatus Pharmaceuticals (NASDAQ:CNAT): conference call & webcast at 12:00 pm ET with liver disease expert to discuss functionally cured HCV patients with residual liver fibrosis/cirrhosis, an unmet medical need.
-
Wednesday (2/21): RBC Global Healthcare Conference, New York. Celgene (NASDAQ:CELG); Spark Therapeutics (NASDAQ:ONCE); Arena Pharmaceuticals (NASDAQ:ARNA); ImmunoGen (NASDAQ:IMGN); Intra-Cellular Therapies (NASDAQ:ITCI); Xencor (NASDAQ:XNCR); Marinus Pharmaceuticals (NASDAQ:MRNS); Intercept Pharmaceuticals (NASDAQ:ICPT); Gilead Sciences (NASDAQ:GILD); Immune Design (NASDAQ:IMDZ); PTC Therapeutics (NASDAQ:PTCT); KemPharm (NASDAQ:KMPH); Oncolytics Biotech (ONCYF); Radius Health (NASDAQ:RDUS); Iovance Biotherapeutics (NASDAQ:IOVA); Dynavax Technologies (NASDAQ:DVAX); Corbus Pharmaceuticals (NASDAQ:CRBP); PDL BioPharma (NASDAQ:PDLI); Addus HomeCare (NASDAQ:ADUS); Flexion Therapeutics (NASDAQ:FLXN); Ra Pharmaceuticals (NASDAQ:RARX); Spectrum Pharmaceuticals (NASDAQ:SPPI); Merrimack Pharmaceuticals (NASDAQ:MACK); Accuray (NASDAQ:ARAY); AcelRx Pharmaceuticals (NASDAQ:ACRX); Pacira Pharmaceuticals (NASDAQ:PCRX).
-
Thursday (2/22): Herbalife (NYSE:HLF) Q4 results.
-
Friday (2/23): FDA action date for Roche's (OTCQX:RHHBY) hemophilia A med emicizumab and Kempharm's (KMPH) pain med Apadaz (benzhydrocodone acetaminophen).